New developments in Toll-like receptor targeted therapeutics.

@article{Connolly2012NewDI,
  title={New developments in Toll-like receptor targeted therapeutics.},
  author={Dympna J. Connolly and Luke A J O'Neill},
  journal={Current opinion in pharmacology},
  year={2012},
  volume={12 4},
  pages={510-8}
}
Toll-like receptors (TLRs) play a crucial role in host defence and inflammation. Given that a significant amount of evidence implicates TLRs in the pathogenesis of immune diseases and cancer, and their activation occurs early in the inflammatory cascade, they are attractive targets for novel therapeutic agents. Potential therapeutics include TLR-targeted antibodies, small molecules and nucleic acid based drugs. Agonists are being tested in vaccines against hepatitis C and influenza as well as… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Similar Papers

Loading similar papers…